A high-level blueprint to begin the journey
Grant M. Wood, FHL7
Technology Executive in Clinical Genomics * Business, IT Strategy * Board member
Despite its promise, the adoption of clinical genomics as standard of care has been slow. In this blog post, we will examine the major issues affecting clinical adoption and discuss what needs to happen next.
Make sure you take a look at the Perspective Report that goes into more depth on this topic. There is also a one-page factsheet summary with Executive highlights. And finally, to carry this conversation beyond this post, take two minutes to fill out the survey to get your score on the issues with the highest priority.
Follow this unique activity at making clinical genomics standard of care at #movingforwardblog and #genomicsnetwork